Cover Image
市場調查報告書

糖化血紅蛋白A1c的監測的全球市場

Hemoglobin A1c Monitoring

出版商 Global Industry Analysts, Inc. 商品編碼 121098
出版日期 內容資訊 英文 266 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
糖化血紅蛋白A1c的監測的全球市場 Hemoglobin A1c Monitoring
出版日期: 2016年05月01日 內容資訊: 英文 266 Pages
簡介

本報告是針對糖化血紅蛋白(Hb)A1c監測的全球市場。以2012-2020年期間為對象,包含其中市價的變化及產品實驗(糖化血紅蛋白化驗,糖化血紅蛋白檢測)並以地區(美國、加拿大、日本、歐洲、亞洲及大洋州、中南美、其他)分別做出檢證和預想。且有過去七年間的市場概說及參與27間公司情報,概要如下:

第1章 導論、測量方法、產品的定義

  • 測量的可信度及報告範圍
  • 免責聲明
  • 數據的解讀
    • 測量技術與分析
  • 產品定義與測量範圍
    • 糖化血紅蛋白化驗
    • 糖化血紅蛋白檢測

第2章 內容提要

  • 市場概略
    • 基本知識
    • 主要問題
    • 糖尿病患者增多 - 主要原因
    • 高齡化造成糖尿病人口增加
    • 市場成長背景
    • 開發中國家:未來的成長
    • 新興國家的醫療支出增加
    • 開發中國家的產品線及相關製造業
    • 固定的基本檢查
    • 定期HgA1c檢查可避免心臟病風險
    • 糖尿病診斷:HgA1c檢查的機會
    • HgA1c檢查及目的是否正確
    • 糖化血紅蛋白檢測:鞏固初期糖尿病診斷
    • 技術開發推進糖尿病診斷
    • POCT:販售的機會
    • POCT造成的競爭
    • POCT的優越性
    • POCT的主要檢查方式
    • 免疫檢查
    • 硼酸親和層析法
    • 微光學檢測
    • 居家觀察:精確度問題
    • 糖化白蛋白可能威脅到HgA1c檢查?
    • 糖化血紅蛋白過高的致死風險
    • 影響到HgA1c檢測市場的CBGM設備及非侵入性的血糖計
    • 歐洲心臟病協會(ESC)與美國糖尿病協會(ADA)對HgA1c檢測的新標準
    • 競爭市場
  • 糖尿病
    • 糖尿病的原因
    • 糖尿病的種類
    • 糖尿病主要種類
    • 預想的併發症
    • 腎臟病
    • 糖尿病性神經障礙
    • 視網膜
    • 感染及傷口無法痊癒
    • 性無能
    • 牙周病
    • 心臟疾病
    • 糖尿病的重要統計數據
    • 全球糖尿病患者數
    • 糖尿病治療的選擇
    • 兩種口服糖尿病藥物
    • 胰島素治療的副作用
    • 不到7%的HgA1c檢測減國
    • 常見糖尿病處理
  • 產品概要
    • 糖化血紅蛋白 – 概述
    • 糖化血紅蛋白A1c – 解說
    • HbA1c監測
    • A1c是什麼
      • 1. HbA1c實驗室檢測
      • 2. 糖化血紅蛋白醫護點測試及監測
    • 糖化血紅蛋白A1c測試
    • HbA1c測試數據的解釋
    • HbA1c檢測結果
    • HbA1c檢測的臨床應用
    • HbA1c檢測的優點及評價
    • HbA1c檢測的風險
    • 格力糖化血紅蛋白的檢測方式
    • 選擇HbA1c檢測的理由
    • 對血糖控制和併發症的大規模臨床試驗(DCCT)
    • Kumamoto and UK Prospective Studies
    • 糖尿病監控用的血糖檢查
    • HbA1c檢測的種類
    • HbA1c實驗室測驗
    • 糖化血紅蛋白醫護點測試及監測
    • 糖化糖化血紅蛋白檢測標準化
    • 全美格力糖化血紅蛋白標準化程序(NGSP)的HbA1c標準
    • 世界臨床化學協會(IFCC)的HbA1c標準
    • HbA1c數據報告
  • 產品認同,發售
  • 最近市場動向
  • 主要相關企業
  • 全球市場

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞洲大洋州
    • 中國
    • 印度
    • 其他
  • 中南美
  • 其他

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1218

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 25 companies including many key and niche players such as -

Abbott Laboratories
Alere, Inc.
ARKRAY, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definition and Scope of Study
    • HbA1c Laboratory Testing
    • HbA1c Point of Care Testing

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • A Quick Primer
  • Growth Stimulants in a Nutshell
  • Major Concerns
  • Increasing Diabetes Prevalence - A Major Growth Propeller
    • Table 1: Worldwide Prevalence of Diabetes Mellitus by Region (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 2: Incidence of Diabetes in Select Countries (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 3: World's Health Expenditure on Diabetes by Region (2013E): Spending (in US$ Billion) by People Diagnosed with Diabetes in the Age Group 20-79 Years to Treat Diabetes and Manage Associated Complications (includes corresponding Graph/Chart)
    • Table 4: Global Expenditure on Diabetes Treatment (2012): Spending (in US$ Billion) by Income Strata (includes corresponding Graph/Chart)
  • Rapidly Aging Demographics and Growing Incidence of Diabetes: Major Driving Factors
    • Table 5: Elderly Population (60+ Years) as a Percentage of Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 6: Global Aging Population (60+) and their Proportion of Total Population (2012) (includes corresponding Graph/Chart)
  • Increasing Obesity Levels Underpins Market Growth
    • Table 7: Global Obesity Population (2013) (includes corresponding Graph/Chart)
    • Table 8: Prevalence of Adult Obesity in Select Countries (2012) (includes corresponding Graph/Chart)
  • Developing Nations: Future Growth Opportunities
  • Increase in Healthcare Spending in Emerging Markets
    • Table 9: Healthcare Spending as % of GDP in Select Countries (2011) (includes corresponding Graph/Chart)
  • Manufacturers Focus on Offering Products for Developing Markets
  • Near Patient Testing Gaining Ground
  • Regular HbA1c Test Keeps Heart Risk at Bay
  • Diabetes Diagnosis: Opportunities for HbA1c Testing
  • Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
  • Glycosylated Hemoglobin Tests: Paving Way for Early Stage Diabetes Diagnosis
  • Technology Developments Revolutionize Diagnostics in Diabetes Care
  • POC Testing: Positive Opportunities in Store
  • Complex Competitive Environment Prevails in POC Diagnostics Market
  • POC HbA1c Tests: Significant Advantages over Lab Tests
  • Major Testing Methods in POC HbA1c Tests
  • Immunoassays
  • Boronate Affinity Chromatography
  • Micro-Optical Detection Methods
    • Select HbA1c POC Tests in the Market - A Comparison
  • Home Monitoring: Laced with Accuracy Concerns
  • Glycated Albumin - A Potential Threat to HbA1c?
  • Higher Levels of Glycosylated Hemoglobin Increases Risk of Death
  • Non-Invasive Glucose Meters and CBGM Devices Threatens HbA1c Market
  • ESC and ADA Release Revised Guidelines for HbA1c Testing
  • Competitive Landscape
    • Table 10: Leading Players in the Global HbA1c Reagent Market (2012): Percentage Breakdown of Revenues for Bayer Diabetes Care, Siemens, and Others (includes corresponding Graph/Chart)

2. DIABETES - A BRIEF PROFILE OF THE DISEASE

  • What Causes Diabetes?
  • Types of Diabetes
  • Major Types of Diabetes
  • Likely Complications
  • Nephropathy (Kidney Disease)
  • Diabetic Neuropathy (Nerve Damage)
  • Retinopathy (Damage to the Eye and Blindness)
  • Poor Healing of Infections and Wounds
  • Impotence in Men
  • Periodontal Disease
  • Cardiovascular Disease
    • Interpreting the A1c Range
    • Blood Glucose Level Guidelines in the US
  • A Glance at Key Diabetes Statistics
    • Table 11: World Diabetes and Population Statistics (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 12: World Diabetes and Population Statistics (in Million) by Region (2013E & 2035P) - Breakdown by Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific (includes corresponding Graph/Chart)
  • Prevalence of Diabetes in Various Parts of the World
    • Table 13: Global Prevalence of Diabetes Mellitus (in Million) by Gender (2013E) - Breakdown by Region for Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific (includes corresponding Graph/Chart)
    • Table 14: Global Prevalence of Diabetes Mellitus (in Million) by Age Group (2013) - Breakdown by Region for Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific Region (includes corresponding Graph/Chart)
    • Table 15: World Diabetes Market (2013 & 2035): Top 10 Regions with Highest Number of People Diagnosed with Diabetes (in Million) in Age Group 20-79 years (includes corresponding Graph/Chart)
    • Table 16: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region (2013E) (includes corresponding Graph/Chart)
    • Table 17: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region (2013E) (includes corresponding Graph/Chart)
  • Therapeutic Options for Diabetes
  • Oral Medications for Type 2 Diabetes
  • Side Effects of Insulin Therapy
  • Maintaining A1c Test Result Below 7%
  • Common Diabetes Management Practices

3. PRODUCT OVERVIEW

  • Hemoglobin - A Brief
  • Hemoglobin A1c- Description
  • HbA1c Monitoring
  • What is A1c?
    • 1. HbA1c Laboratory Testing
    • 2. HbA1c Point of Care Testing & Self-Monitoring
  • Hemoglobin A1c (HbA1c) Test
  • Interpreting HbA1c Test Readings
  • Result of Hemoglobin A1c Test
  • Clinical Use of A1c Testing
  • Advantages of A1c Assessment & Interpretation
  • Risks Associated with HbA1c Testing
  • Methods of Measurement for Glycohemoglobin
  • Why Opt for HbA1c Testing?
  • The Diabetes Control & Complications Trial (DCCT)
  • The Kumamoto and UK Prospective Studies
  • Glycemia Tests Used in Monitoring Diabetes
    • Urine Glucose Testing
    • Glycated Protein Testing
    • Table 18: Relation Between A1c Level and Mean Plasma Glucose Levels
  • HbA1c Test Types
  • HbA1c Laboratory Testing
    • Analytical Techniques Used for Quantifying HbA1c in Labs
    • Standardization of HbA1c Results
    • Table 19: CAP Accuracy Grading for HbA1c Measurements (2007-2013)
      • Select Laboratory-based HbA1c Testing Products/Analyzers
  • HbA1c Point of Care Testing & Self-Monitoring
    • Select Point of Care HbA1c Testing Products/ Analyzers
  • Standardization of Glycated Hemoglobin Testing
  • NGSP Standardization of HbA1c
  • IFCC Standardization of HbA1c
  • HbA1c Reporting
    • A1c (%) and Corresponding eAG Number (in mg/dl or mmol/l)

4. PRODUCT APPROVALS/INTRODUCTIONS

  • Piramal Enterprises Unveils Instant QDx Range of Diagnostic Devices
  • Roche Launches Cobas B 101 System for Managing Metabolic Syndrome
  • Convergys(r) Launches POC HbA1c Analyzer
  • Sanofi Showcases MyStar Extra(r) Self-Monitoring Meter
  • Roche Unveils New HbA1c Test for Diagnosis of Diabetes
  • Erba Mannheim Unveils New Hb-Vario HPLC System
  • EKF Launches Quo-Test POC HbA1c Analyzer
  • Roche Receives FDA Approval for COBAS INTEGRA 800 Tina-quant HbA1cDx Assay
  • Beckman Coulter Gets FDA Clearance for Hemoglobin A1c Assay Tests
  • Pointe Scientific Launches A1c Automated Assay for Beckman DXC 600 Analyser
  • Dynacare Upgrades Hematology Software in Hemoglobin A1C Testing
  • Tosoh Bioscience Introduces GX Glycohemoglobin Analyzer
  • Siemens Secures CE Marking for DCA HbA1c Test Kit
  • EKF Obtains CE Mark for Quo-Lab POC HbA1c Analyser
  • Streck Launches A1c-Cellular Linearity Verification Material
  • Abbott Obtains CE Marking for ARCHITECT HbA1c (IA) Fully Automated Assay
  • Tosoh Bioscience Develops ST AIA-PACK HbA1c Assay
  • Trinity Obtains FDA Approval for Premier Hb9210 HbA1c Device
  • Siemens Launches Fortified Version of DCA Vantage Analyzer
  • Tosoh Launches New Assay on its AIA-600II and AIA-360 Analyzers

5. RECENT INDUSTRY ACTIVITY

  • Quest Diagnostics Sells HemoCue Business to Radiometer
  • Techne Takes Over Bionostics
  • Express Diagnostics Takes Over Eveia Medical
  • BioHermes Enters into Agreement to Acquire HbA1c Technology from Scripps Laboratories
  • HemoCue America Inks 5-Year Agreement with ARC
  • Bio-Rad Laboratories Inks Development Agreement with Inpeco
  • Danaher Acquires Beckman Coulter
  • Alere Purchases Additional Shares of Axis-Shield
  • EKF Diagnostics Inaugurates New Manufacturing Plant in the UK
  • MinuteClinic Signs Agreement with Axis-Shield
  • Trinity Inks Distribution Agreement with Menarini for Premier Hb9210

6. FOCUS ON SELECT PLAYERS

  • Abbott Laboratories (US)
  • ARKRAY, Inc. (Japan)
  • Axis-Shield plc (UK)
  • Bayer Healthcare Diabetes Care (US)
  • Beckman Coulter, Inc. (US)
  • Bio-Rad Laboratories Inc (US)
  • Diazyme Laboratories Inc. (US)
  • EKF Diagnostics Holdings Plc (UK)
  • HEMOCUE(r) AB (Sweden)
  • Infopia Co. Ltd. (South Korea)
  • Menarini Diagnostics Ltd. (UK)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare Diagnostics (Germany)
  • Tosoh Bioscience, Inc (US)
  • Trinity Biotech plc (Ireland)

7. GLOBAL MARKET PERSPECTIVE

    • Table 20: World Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 22: World 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 23: World Recent Past, Current & Future Analysis for Laboratory-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for Laboratory-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 25: World 15-Year Perspective for Laboratory- based HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current & Future Analysis for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 28: World 15-Year Perspective for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • HbA1c - Increasingly Moving into Physician's Office
    • HbA1c Testing for Diabetes Detection Gains Support
      • ADA Recommends HbA1c Test for Diabetes Diagnosis
      • ADA Recommends New Guidelines for HbA1c Testing for Certain Patients
      • Rising Inclination towards CLIA-Waived Tests
      • Need for Further Stringency in Requirements Arises
    • Healthcare Reform Legislation: Impact on Diabetes Diagnostics
    • US Near Patient HbA1c Testing - A Highly Consolidated Market
    • Table 29: Leading Players in the US Near Patient HbA1c Testing Market (2013): Percentage Share Breakdown of Revenues for Siemens, Axis-Shield, and Others (includes corresponding Graph/Chart)
    • Diabetes Statistics in North America and Caribbean Region
    • Table 30: North American and Caribbean Regional Population and Diabetes Prevalence Statistics (2013E) - Top Regions with High Prevalence of Diabetes by Age Group and Gender (includes corresponding Graph/Chart)
    • Table 31: Diabetes and Population Statistics in North America and Caribbean Region (2013 & 2035) (includes corresponding Graph/Chart)
    • Diabetes Statistics in the US - An Overview
      • Age Factor
    • Table 32: Number of Diabetics by Gender in the US (2013E) (in '000s) (includes corresponding Graph/Chart)
    • Table 33: Number of Diabetics in the US by Age Group (2013E) (in '000s) (includes corresponding Graph/Chart)
      • Prevalence by Race/Ethnicity
    • Table 34: US Market for Diabetes (2012): Percentage Breakdown of Prevalence by Race/Ethnicity - Non-Hispanic Blacks and Non-Hispanic Whites (includes corresponding Graph/Chart)
      • Mean HbA1c Scores at National Level
      • Economic Burden of Diabetes in the US
    • Table 35: Direct Medical Expenditure on Diabetes Management in the US (2012): Percentage Share Breakdown of Costs Incurred by Component (includes corresponding Graph/Chart)
    • Table 36: Indirect Costs of Diabetes in the US (2012): Percentage Share Breakdown by Component (includes corresponding Graph/Chart)
    • Product Approvals/Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 37: US Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 38: US Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011(includes corresponding Graph/Chart)
    • Table 39: US 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics in Canada
    • Table 40: Adult Diabetes Population by Gender in Canada (2013) (In '000s) (includes corresponding Graph/Chart)
    • Table 41: Adult Diabetes Population by Age Group in Canada (2013) (In '000s) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 42: Canadian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 43: Canadian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 44: Canadian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • ARKRAY, Inc. - A Major Player
  • B. Market Analytics
    • Table 45: Japanese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 46: Japanese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 47: Japanese 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Positive Outlook for Diabetes Diagnostics Market in Europe
    • Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption
    • Competitive Environment
    • Table 48: Leading Players in the European Point-of-Care HbA1c Tests Market (2011): Percentage Share Breakdown of Revenues for Axis-Shield, Hemocue, Siemens Healthcare Diagnostics, and Others (includes corresponding Graph/Chart)
    • A Glance at Key Diabetes Statistics in Europe
    • Table 49: Diabetes and Population Statistics in Europe (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 50: European Population and Diabetes Prevalence Statistics (2013E) - Select Regions with High Prevalence of Diabetes for Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 51: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 52: European Historic Review for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 53: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 54: European Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 55: European 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)
    • Table 56: European 15-Year Perspective for HbA1c Monitoring by Segment -Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 57: French Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 58: French Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 59: French 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Product Approvals/Introductions
    • Siemens Healthcare Diagnostics - A Key Player
  • B. Market Analytics
    • Table 60: German Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 61: German Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 62: German 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 63: Italian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 64: Italian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 65: Italian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics & Management - An Insight
      • Rising Obesity Cases - Increased Risk of Diabetes
      • Type 1 Diabetes in Children
    • Table 66: Number of Type 1 Diabetics Per 100,000 Children in Select Countries (2011) (includes corresponding Graph/Chart)
    • NHS England Launches Action for Diabetes Plan
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 67: UK Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 68: UK Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 69: UK 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
    • Product Launch
  • B. Market Analytics
    • Table 70: Spanish Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 71: Spanish Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 72: Spanish 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 73: Russian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 74: Russian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 75: Russian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 76: Rest of Europe Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 77: Rest of Europe Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 78: Rest of Europe 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics - An Overview
    • Table 79: Diabetes and Population Statistics in Western Pacific (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 80: Western Pacific Population and Diabetes Prevalence Statistics (2013E) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
    • Table 81: Diabetes and Population Statistics in South East Asia (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 82: South East Asian Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific Historic Review for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 85: Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)
    • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 88: Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Increasing Diabetes Incidence Spurs Growth in Diabetes Diagnostics Market
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 89: Chinese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Chinese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 91: Chinese 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Outlook
    • HbA1c Testing on Growth Spree
      • Growth Stimulants & Challenges in a Nut Shell
    • Rising Diabetes Cases - Opportunities for HbA1c Monitoring Market
    • Product Launch
  • B. Market Analytics
    • Table 92: Indian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 93: Indian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 94: Indian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics in Australia
    • Table 95: Diabetes Population Breakdown by Age Group in Australia (2011-12) (includes corresponding Graph/Chart)
    • Infopia Co. Ltd. (South Korea) - A Major Player
  • B. Market Analytics
    • Table 96: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 97: Rest of Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 98: Rest of Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Diabetes in Latin America - A Glance at Key Statistics
    • Table 99: Diabetes and Population Statistics in Central and South America (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 100: Central and South American Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 101: Latin American Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 102: Latin American Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 103: Latin American 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics in Africa and the Middle East
    • Table 104: African Diabetes and Population Statistics (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 105: African Population and Diabetes Prevalence Statistics (2013) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
    • Table 106: Diabetes and Population Statistics in Middle East and North Africa (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 107: Middle East and North African Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 108: Rest of World Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 109: Rest of World Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 110: Rest of World 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top